Halozyme Therapeutics shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Halozyme Therapeutics by T. Rowe Price Associates
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2013-03-31 | $4.3M | 754k | 5.77 |
2012-12-31 | $10M | 1.5M | 6.71 |
2012-09-30 | $12M | 1.6M | 7.56 |
2012-06-30 | $14M | 1.5M | 8.86 |
2012-03-31 | $12M | 961k | 12.76 |
2011-12-31 | $8.0M | 846k | 9.51 |
2011-09-30 | $5.1M | 833k | 6.14 |
2011-08-12 | $6.5M | 946k | 6.91 |
2011-03-31 | $6.4M | 949k | 6.71 |
2010-12-31 | $7.4M | 938k | 7.92 |